309 related articles for article (PubMed ID: 26634453)
1. Botulinum neurotoxin type A in the treatment of classical Trigeminal Neuralgia (BoTN): study protocol for a randomized controlled trial.
Burmeister J; Holle D; Bock E; Ose C; Diener HC; Obermann M
Trials; 2015 Dec; 16():550. PubMed ID: 26634453
[TBL] [Abstract][Full Text] [Related]
2. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial.
Zhang H; Lian Y; Ma Y; Chen Y; He C; Xie N; Wu C
J Headache Pain; 2014 Sep; 15(1):65. PubMed ID: 25263254
[TBL] [Abstract][Full Text] [Related]
3. The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial.
Brændvik SM; Roeleveld K; Andersen GL; Raftemo AE; Ramstad K; Majkic-Tajsic J; Lamvik T; Lund B; Follestad T; Vik T
Trials; 2017 Feb; 18(1):58. PubMed ID: 28166806
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of botulinum toxin type A in trigeminal neuralgia.
Zúñiga C; Díaz S; Piedimonte F; Micheli F
Arq Neuropsiquiatr; 2008 Sep; 66(3A):500-3. PubMed ID: 18813708
[TBL] [Abstract][Full Text] [Related]
5. Botulinum toxin and intractable trigeminal neuralgia.
Türk U; Ilhan S; Alp R; Sur H
Clin Neuropharmacol; 2005; 28(4):161-2. PubMed ID: 16062093
[TBL] [Abstract][Full Text] [Related]
6. Injections of botulinum toxin type a produce pain alleviation in intractable trigeminal neuralgia.
Allam N; Brasil-Neto JP; Brown G; Tomaz C
Clin J Pain; 2005; 21(2):182-4. PubMed ID: 15722812
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
Attal N; de Andrade DC; Adam F; Ranoux D; Teixeira MJ; Galhardoni R; Raicher I; Üçeyler N; Sommer C; Bouhassira D
Lancet Neurol; 2016 May; 15(6):555-65. PubMed ID: 26947719
[TBL] [Abstract][Full Text] [Related]
8. Single-dose botulinum toxin type a compared with repeated-dose for treatment of trigeminal neuralgia: a pilot study.
Zhang H; Lian Y; Xie N; Chen C; Zheng Y
J Headache Pain; 2017 Aug; 18(1):81. PubMed ID: 28799056
[TBL] [Abstract][Full Text] [Related]
9. Acute treatment of trigeminal neuralgia with onabotulinum toxin A.
Zúñiga C; Piedimonte F; Díaz S; Micheli F
Clin Neuropharmacol; 2013; 36(5):146-50. PubMed ID: 24045604
[TBL] [Abstract][Full Text] [Related]
10. Increasing relief with repeated botulinum neurotoxin A injections in a rare case of hemi facial spasm with contralateral trigeminal autonomic orofacial pain and occipital neuralgia: A case report.
Punj J; Singh P
Toxicon; 2023 Jun; 228():107120. PubMed ID: 37031873
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review.
Hu Y; Guan X; Fan L; Li M; Liao Y; Nie Z; Jin L
J Headache Pain; 2013 Aug; 14(1):72. PubMed ID: 23964790
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Single Botulinum Toxin Type A (Botox®) Injection for Relief of Upper Trapezius Myofascial Trigger Point: A Randomized, Double-Blind, Placebo-Controlled Study.
Kwanchuay P; Petchnumsin T; Yiemsiri P; Pasuk N; Srikanok W; Hathaiareerug C
J Med Assoc Thai; 2015 Dec; 98(12):1231-6. PubMed ID: 27004309
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study.
Schott Andersen AS; Maarbjerg S; Noory N; Heinskou TB; Forman JL; Cruccu G; Ashina M; Bendtsen L
Lancet Neurol; 2022 Nov; 21(11):994-1003. PubMed ID: 36113495
[TBL] [Abstract][Full Text] [Related]
14. Trigeminal Neuralgia With Extraoral Trigger Zone Successfully Treated With Intraoral Injections of Botulinum Toxin: A Case Report.
Dinan JE; Smith A; Hawkins JM
Clin Neuropharmacol; 2020; 43(5):162-163. PubMed ID: 32947428
[TBL] [Abstract][Full Text] [Related]
15. Neuromodulators for Atypical Facial Pain and Neuralgias: A Systematic Review and Meta-Analysis.
Do TM; Unis GD; Kattar N; Ananth A; McCoul ED
Laryngoscope; 2021 Jun; 131(6):1235-1253. PubMed ID: 33037835
[TBL] [Abstract][Full Text] [Related]
16. Is Botulinum Toxin Type A a Valuable Adjunct During Femoral Lengthening? A Randomized Trial.
Park H; Shin S; Shin HS; Kim HW; Kim DW; Lee DH
Clin Orthop Relat Res; 2016 Dec; 474(12):2705-2711. PubMed ID: 27506971
[TBL] [Abstract][Full Text] [Related]
17. Effect of ultrasound-guided injection of botulinum toxin type A into shoulder joint cavity on shoulder pain in poststroke patients: study protocol for a randomized controlled trial.
Zheng P; Shi Y; Qu H; Han ML; Wang ZQ; Zeng Q; Zheng M; Fan T
Trials; 2024 Jun; 25(1):418. PubMed ID: 38937804
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial.
Zakrzewska JM; Palmer J; Morisset V; Giblin GM; Obermann M; Ettlin DA; Cruccu G; Bendtsen L; Estacion M; Derjean D; Waxman SG; Layton G; Gunn K; Tate S;
Lancet Neurol; 2017 Apr; 16(4):291-300. PubMed ID: 28216232
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of botulinum toxin for the treatment of trigeminal and postherpetic neuralgia: a systematic review with meta-analyses.
Shackleton T; Ram S; Black M; Ryder J; Clark GT; Enciso R
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Jul; 122(1):61-71. PubMed ID: 27260275
[TBL] [Abstract][Full Text] [Related]
20. Botulinum neurotoxin type A for the treatment of pain: not just in migraine and trigeminal neuralgia.
Sandrini G; De Icco R; Tassorelli C; Smania N; Tamburin S
J Headache Pain; 2017 Dec; 18(1):38. PubMed ID: 28324318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
